Publication year |
Author |
Location |
Age |
Sex |
Comorbidities |
Infection type |
Antibiotic resistance |
1992
|
Aragone et al.[2] |
Argentina |
63 |
Male |
Diabetes mellitus type 2, aortic valve replacement, poliomyelitis |
Infective endocarditis |
Ampicillin, cephalothin |
2001 |
Johansen et al. [8] |
Denmark |
28 |
Female |
Situs inversus, double-outlet right ventricle, ventricular septal defect (VSD), pulmonary stenosis, multiple cardiovascular surgeries |
Infective endocarditis |
No available data, culture unable to be obtained from abscess |
2005 |
Chi et al. [4] |
Taiwan |
65 |
Male |
Alcoholic hepatitis, chronic renal disease |
Spondylodiscitis |
Trimethoprim/sulfamethoxazole |
2007 |
Mert et al. [12] |
Turkey |
36 |
Male |
Mental retardation |
Infective endocarditis |
No known resistance |
2011 |
Suel et al. [9] |
France |
79 |
Female |
Atrial fibrillation, transient ischemic attack, hypertension |
Infective endocarditis |
No known resistance |
2011 |
Nseir et al. [11] |
Israel |
31 |
Male |
Healthy |
Bacteremia |
Ceftriaxone and aztreonam |
2013 |
Howe et al. [6] |
Singapore |
86 |
Female |
Vertebral compression fractures, tibial plateau stress fracture |
Osteomyelitis |
No available data, polymicrobial infection |
2013 |
Chiu and Wang [5] |
Singapore |
34 |
Male |
Healthy |
Septic arthritis |
Ampicillin ampicillin/sulbactam |
2016 |
Rapsinski et al. [15] |
United States |
57 |
Male |
Gout, chronic alcohol use |
Infective endocarditis |
Ampicillin/sulbactam, cefazolin |
2017 |
Jerónimo et al. [10] |
Portugal |
22 |
Male |
Chronic kidney disease, peritoneal dialysis |
Peritonitis |
No available data |
2018 |
Almuzara et al. [17] |
Argentina |
56 |
Male |
Alcohol use disorder, vascular insufficiency |
Burn wound infection |
No known resistance |
2018 |
Almuzara et al. [17] |
Argentina |
36 |
Male |
Alcohol use disorder |
Burn wound infection |
No known resistance |
2018 |
Huang et al. [3] |
Taiwan |
55 |
Male |
Diabetes mellitus type 2, buccal cancer, community-acquired infection |
Meningitis |
No known resistance |
2018 |
Huang et al. [3] |
Taiwan |
66 |
Female |
Spontaneous intracerebral hemorrhage, external ventricular drainage |
Meningitis |
No known resistance |
2018 |
Huang et al. [3] |
Taiwan |
79 |
Male |
Chronic obstructive pulmonary disease, respiratory failure, nosocomial infection |
Meningitis |
No known resistance |
2018 |
Huang et al. [3] |
Taiwan |
78 |
Female |
Healthy |
Meningitis |
No known resistance |
2019 |
Gani et al. [16] |
United States |
63 |
Male |
Resistant HIV/AIDS |
Bacteremia |
No resistance against cefepime, ceftazidime, levofloxacin, meropenem; resistance against piperacillin/tazobactam unable to be determined |
2020 |
Goldberg et al. [14] |
United States |
72 |
Male |
End-stage renal disease, immunoglobulin A (IgA) nephropathy, atrial fibrillation, heart failure with reduced ejection fraction, obesity, chronic venous stasis |
Bacteremia |
No known resistance |
2021 |
Ezeokoli et al. [13] |
United States |
81 |
Male |
Coronary artery disease, atrial fibrillation, heart failure, chronic kidney disease, diabetes mellitus type 2, CVA |
Bacteremia |
No known resistance |
2021 |
Gupta et al. [7] |
India |
53 |
Male |
Diabetes mellitus type 2, asthma |
Leg wound infection |
Ciprofloxacin, ceftazidime, amikacin, piperacillin-tazobactam, aztreonam |
2022 |
This case report |
United States |
83 |
Male |
Diabetes mellitus type 2, hypertension, coronary artery disease, prostate cancer, COVID-19 pneumonia |
Urinary tract infection |
Ciprofloxacin, levofloxacin |